Biomedical devices in the blood flow disturb the fine-tuned balance of pro-and anti-
coagulant factors in blood and vessel wall. Numerous technologies have been suggested to …

The short‐and long‐term thrombogenicity of implant materials is still unpredictable, which is
a significant challenge for the treatment of cardiovascular diseases. A knowledge‐based …

Abstract Poly (vinyl alcohol)(PVA) has shown promise as a biomaterial for cardiovascular
application. However, its antifouling properties prevent in vivo endothelialization. This work …

Blood-contacting medical devices, such as vascular stents, intravascular catheters, and
artificial heart valves, frequently encounter complications in clinical practice, including …

Virtually all blood-contacting medical implants and devices initiate immunological events in
the form of thrombosis and inflammation. Typically, patients receiving such implants are also …

The therapeutic efficacy of a cardiovascular device after implantation is highly dependent on
the host-initiated complement and coagulation cascade. Both can eventually trigger …

From stents and large-diameter vascular grafts, to mechanical heart valves and blood
pumps, blood-contacting devices are enjoying significant clinical success owing to the …

A highly oriented poly (l-lactic acid)(PLLA), with a blood vessel-like biomimetic structure,
was fabricated using solid-phase hot drawing technology and homo-epitaxial crystallization …

Endothelialized oxygenator devices (EndOxy) with a physiological, nonthrombogenic, and
anti‐inflammatory surface offer the potential to overcome current shortcomings of …

In biomaterial development, the design of material surfaces that mimic the extra-cellular
matrix (ECM) in order to achieve favorable cellular instruction is rather challenging …